CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines.
Breast Cancer Res Treat
; 173(3): 521-532, 2019 Feb.
Article
in En
| MEDLINE
| ID: mdl-30411242
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Variation
/
Breast Neoplasms
/
Receptors, Estrogen
/
Cytochrome P-450 CYP2D6
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Systematic_reviews
Limits:
Female
/
Humans
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2019
Type:
Article
Affiliation country:
Canada